BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31346528)

  • 1. Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression.
    Tsaouli G; Ferretti E; Bellavia D; Vacca A; Felli MP
    J Immunol Res; 2019; 2019():5601396. PubMed ID: 31346528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The common oncogenomic program of NOTCH1 and NOTCH3 signaling in T-cell acute lymphoblastic leukemia.
    Choi SH; Severson E; Pear WS; Liu XS; Aster JC; Blacklow SC
    PLoS One; 2017; 12(10):e0185762. PubMed ID: 29023469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia.
    Mirandola L; Chiriva-Internati M; Montagna D; Locatelli F; Zecca M; Ranzani M; Basile A; Locati M; Cobos E; Kast WM; Asselta R; Paraboschi EM; Comi P; Chiaramonte R
    J Pathol; 2012 Apr; 226(5):713-22. PubMed ID: 21984373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia.
    Passaro D; Irigoyen M; Catherinet C; Gachet S; Da Costa De Jesus C; Lasgi C; Tran Quang C; Ghysdael J
    Cancer Cell; 2015 Jun; 27(6):769-79. PubMed ID: 26058076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathymic Notch3 and CXCR4 combinatorial interplay facilitates T-cell leukemia propagation.
    Ferrandino F; Bernardini G; Tsaouli G; Grazioli P; Campese AF; Noce C; Ciuffetta A; Vacca A; Besharat ZM; Bellavia D; Screpanti I; Felli MP
    Oncogene; 2018 Dec; 37(49):6285-6298. PubMed ID: 30038265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
    Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
    Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies.
    Bernasconi-Elias P; Hu T; Jenkins D; Firestone B; Gans S; Kurth E; Capodieci P; Deplazes-Lauber J; Petropoulos K; Thiel P; Ponsel D; Hee Choi S; LeMotte P; London A; Goetcshkes M; Nolin E; Jones MD; Slocum K; Kluk MJ; Weinstock DM; Christodoulou A; Weinberg O; Jaehrling J; Ettenberg SA; Buckler A; Blacklow SC; Aster JC; Fryer CJ
    Oncogene; 2016 Nov; 35(47):6077-6086. PubMed ID: 27157619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotactic Cues for NOTCH1-Dependent Leukemia.
    Piovan E; Tosello V; Amadori A; Zanovello P
    Front Immunol; 2018; 9():633. PubMed ID: 29666622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow mesenchymal stem cells in microenvironment transform into cancer-associated fibroblasts to promote the progression of B-cell acute lymphoblastic leukemia.
    Pan C; Liu P; Ma D; Zhang S; Ni M; Fang Q; Wang J
    Biomed Pharmacother; 2020 Oct; 130():110610. PubMed ID: 34321159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch pathway promotes ovarian cancer growth and migration via CXCR4/SDF1α chemokine system.
    Chiaramonte R; Colombo M; Bulfamante G; Falleni M; Tosi D; Garavelli S; De Simone D; Vigolo E; Todoerti K; Neri A; Platonova N
    Int J Biochem Cell Biol; 2015 Sep; 66():134-40. PubMed ID: 26235278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute lymphoblastic leukemia.
    Onciu M
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):655-74. PubMed ID: 19577163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances on NOTCH signaling in T-ALL.
    Tzoneva G; Ferrando AA
    Curr Top Microbiol Immunol; 2012; 360():163-82. PubMed ID: 22673746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia.
    Jost TR; Borga C; Radaelli E; Romagnani A; Perruzza L; Omodho L; Cazzaniga G; Biondi A; Indraccolo S; Thelen M; Te Kronnie G; Grassi F
    J Leukoc Biol; 2016 Jun; 99(6):1077-87. PubMed ID: 26931577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.
    González-García S; Mosquera M; Fuentes P; Palumbo T; Escudero A; Pérez-Martínez A; Ramírez M; Corcoran AE; Toribio ML
    Blood; 2019 Dec; 134(24):2171-2182. PubMed ID: 31530562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies.
    Peled A; Klein S; Beider K; Burger JA; Abraham M
    Cytokine; 2018 Sep; 109():11-16. PubMed ID: 29903571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression.
    Franciosa G; Diluvio G; Gaudio FD; Giuli MV; Palermo R; Grazioli P; Campese AF; Talora C; Bellavia D; D'Amati G; Besharat ZM; Nicoletti C; Siebel CW; Choy L; Rustighi A; Sal GD; Screpanti I; Checquolo S
    Oncogene; 2016 Sep; 35(36):4741-51. PubMed ID: 26876201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch in Leukemia.
    McCarter AC; Wang Q; Chiang M
    Adv Exp Med Biol; 2018; 1066():355-394. PubMed ID: 30030836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model.
    García-Peydró M; Fuentes P; Mosquera M; García-León MJ; Alcain J; Rodríguez A; García de Miguel P; Menéndez P; Weijer K; Spits H; Scadden DT; Cuesta-Mateos C; Muñoz-Calleja C; Sánchez-Madrid F; Toribio ML
    J Clin Invest; 2018 Jul; 128(7):2802-2818. PubMed ID: 29781813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between GLI transcription factors and FOXC1 promotes T-cell acute lymphoblastic leukemia dissemination.
    Tosello V; Bongiovanni D; Liu J; Pan Q; Yan KK; Saccomani V; Van Trimpont M; Pizzi M; Mazzoni M; Dei Tos AP; Amadori A; Zanovello P; Van Vlierberghe P; Yu J; Piovan E
    Leukemia; 2021 Apr; 35(4):984-1000. PubMed ID: 32733009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch in T-ALL: new players in a complex disease.
    Koch U; Radtke F
    Trends Immunol; 2011 Sep; 32(9):434-42. PubMed ID: 21775206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.